Antiangiogenic therapy for patients with glioblastoma: current challenges in imaging and future directions

Expert Rev Anticancer Ther. 2011 May;11(5):653-6. doi: 10.1586/era.11.35.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Bevacizumab
  • Glioblastoma / blood supply
  • Glioblastoma / drug therapy*
  • Humans
  • Quinazolines / pharmacology
  • Quinazolines / therapeutic use
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Quinazolines
  • Bevacizumab
  • cediranib